Back to Screener

Healthcare

NewAmsterdam Pharma Company N.V.(NAMS)

Live Price

Offline

$32.71

+3.09% today

1Y Change

+76.86%

Window

Jun 26, 2025 โ†’ Jun 24, 2026

Market Cap
$3.27B
Revenue Growth
-50.6%
EPS Growth
+31.6%
Dividend Yield
0.0%

Coverage: 250 bars ยท Jun 26, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

NewAmsterdam Pharma Company N.V. (NAMS) is a Healthcare stock with a market cap of $3.27B and listed on NASDAQ. The stock last traded around $32.71 and up 76.9% across the available one-year price window (Jun 26, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of -50.6%, EPS growth of +31.6%, a dividend yield of 0.0%. What stands out right now is revenue -50.6%, EPS +31.6%, free cash flow +7.0% with operating margin -1002.9% and ROIC -33.0%. Valuation already assumes a fairly strong business story at price/sales 145.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines NAMS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

NAMS vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

NAMS

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

NAMS Max Drawdown

-31.41%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for NAMS and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est -0.46
โ€”
โ€”
Est 1092.9B
โ€”
May 14
โ€”
Feb 18, 26
โœ—
-0.63
Est -0.40
-57.5%
32.0B
Est 1252.1B
-97.4%
Feb 18
โ€”
Nov 5, 25
โœ—
-0.41
Est -0.38
-7.9%
348.0B
Est 2399.3B
-85.5%
Nov 5
โ€”
Aug 6, 25
โœ“
-0.15
Est -0.52
+71.2%
22428.2B
Est 3493.7B
+542.0%
Aug 6
โ€”
May 8, 25
โœ—
-0.49
Est -0.45
-8.9%
3223.4B
Est 1458.1B
+121.1%
May 8
โ€”
Feb 26, 25
โœ—
-0.95
Est -0.48
-97.9%
13225.3B
Est 1755.6B
+653.3%
Feb 26
โ€”
Nov 6, 24
โœ“
-0.18
Est -0.48
+62.5%
32516.4B
Est 1872.0B
+1637.0%
Nov 6
โ€”
Aug 7, 24
โœ“
-0.51
Est -0.59
+13.6%
2450.5B
Est 1206.0B
+103.2%
Aug 7
โ€”
May 8, 24
โœ—
-0.62
Est -0.54
-14.8%
1505.1B
Est 1618.9B
-7.0%
May 8
โ€”
Mar 29, 24
โœ“
-0.57
Est -0.60
+5.5%
1753.6B
Est โ€”
โ€”
Mar 29
โ€”
Feb 28, 24
โœ“
-0.54
Est -0.55
+1.8%
1980.3B
Est โ€”
โ€”
Feb 28
โ€”
Aug 7, 23
โœ—
-0.47
Est -0.39
-19.9%
1716.5B
Est โ€”
โ€”
Aug 7
โ€”
Jun 30, 23
โœ—
-0.52
Est -0.44
-17.3%
8648.9B
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 23
โœ—
-2.37
Est -0.61
-289.0%
1491.2B
Est โ€”
โ€”
Mar 31
โ€”
Oct 18, 22
-2.14
Est โ€”
โ€”
5485.9B
Est โ€”
โ€”
Oct 18
โ€”
Jun 30, 22
1.61
Est โ€”
โ€”
48901.4B
Est โ€”
โ€”
Jun 30
โ€”
Mar 30, 22
1.70
Est โ€”
โ€”
51711.3B
Est โ€”
โ€”
Mar 30
โ€”
Dec 31, 21
-1.13
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Dec 31
โ€”
Sep 30, 21
-0.63
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Sep 30
โ€”
Jun 30, 21
-0.32
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jun 30
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener